Page last updated: 2024-10-28

hydralazine and Dilatation, Pathologic

hydralazine has been researched along with Dilatation, Pathologic in 1 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Dilatation, Pathologic: The condition of an anatomical structure's being dilated beyond normal dimensions.

Research Excerpts

ExcerptRelevanceReference
"Marfan syndrome is an inheritable connective tissue disorder with multisystem involvement and variable expression of signs and symptoms, caused by mutations within the fibrillin gene on chromosome 15q21."2.43Pregnancy in Marfan syndrome after aortic root replacement: a case report and review of the literature. ( Elami, A; Ezra, Y; Gilon, D; Ginosar, Y; Pollak, A; Volach, V, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Volach, V1
Elami, A1
Gilon, D1
Pollak, A1
Ginosar, Y1
Ezra, Y1

Reviews

1 review available for hydralazine and Dilatation, Pathologic

ArticleYear
Pregnancy in Marfan syndrome after aortic root replacement: a case report and review of the literature.
    Congenital heart disease, 2006, Volume: 1, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Aortic Diseases; Aortic Dissection; Blo

2006